ArticleJournal of experimental & clinical cancer research : CR2024

Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME.

Juliano Tiburcio de Freitas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.